Covid-19 Research

Research Article

Morchella esculenta Polysaccharide Attenuates Obesity through Ameliorating Adipose and Liver Tissue Inflammation in Obese Mouse Model

Journal of Biomedical Research & Environmental Sciences article abstract with citation details, DOI, publication dates, subject areas, full text links, and references.

View DOI Submit Manuscript

Article Details

Publication record, authors, dates, abstract, and full text access.

Open Access
Article Type Research Article
Subject Medicine Group
OCLC 9528716946
Ata Ur Rehman, Asif Iqbal Khan, Tian Zhiying, Xiaoxiao Zhang, Wen Yuqi, Hazrat Bilal, Duaa Mohammad Abdallah Alsholi, Yi Xin* and Liang Wang*
Issue: Volume3-Issue5
Pages: 488-500
Received: 2022-04-26
Accepted: 2022-05-04
Published: 2022-05-05

Abstract

Morchella esculenta is an edible mushroom known for its high nutritional value and delicious taste. Morchella esculenta polysaccharide has many biological properties, including neuroprotective, nephroprotective, anti-proliferating, tumor-suppressive, and immunostimulatory functions. In this study, Morchella esculenta Polysaccharide (MEP) was evaluated for its anti-inflammatory effects in adipose and liver tissue and for effects on obesity and obesity-associated conditions in High-Fat Diet (HFD)-induced obese mice. After MEP administration, HFD mice exhibited lower body weight, epididymal and subcutaneous fat deposition, and adipocyte sizes, as well as lower Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), Triglycerides (TG), Total Cholesterol (TC) and Fasting Blood Glucose (FBG) than HFD control mice. Furthermore, MEP supplementation attenuates inflammation in the adipose and liver tissue via regulation of Toll-like Receptor 4 (TLR4) and inactivation of nuclear factor kappa B (NF-κB). It also regulates the expression of transforming growth factor beta (TGF-β) and pro-inflammatory cytokines. Moreover, MEP administration restores insulin resistance via inhibiting insulin receptor substrate-1 (IRS-1) in the adipose and liver tissue. In conclusion, MEP may be a promising pharmaceutic approach for body weight reduction, attenuating obesity, and inflammation.

FullText HTML FullText PDF DOI: 10.37871/jbres1470 Crossmark

Certificate of Publication

Certificate of Publication

Copyright

© 2022 Rehman AU, et al. Distributed under Creative Commons CC-BY 4.0 Creative CommonsAttribution

How to cite this article

Rehman AU, Khan AI, Zhiying T, Zhang X, Yuqi W, Bilal H, Abdallah Alsholi DM, Xin Y, Wang L. Morchella esculenta Polysaccharide Attenuates Obesity through Ameliorating Adipose and Liver Tissue Inflammation in Obese Mouse Model. J Biomed Res Environ Sci. 2022 May 05; 3(5): 488-500. doi: 10.37871/jbres1470, Article ID: JBRES1470, Available at: https://www.jelsciences.com/articles/jbres1470.pdf

Subject area(s)

Nutrition

References

  1. Bray GA, Frühbeck G, Ryan DH, Wilding JP. Management of obesity. Lancet. 2016 May 7;387(10031):1947-56. doi: 10.1016/S0140-6736(16)00271-3. Epub 2016 Feb 10. PMID: 26868660.
  2. Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond). 2008 Sep;32(9):1431-7. doi: 10.1038/ijo.2008.102. Epub 2008 Jul 8. PMID: 18607383.
  3. El-Sayed Moustafa JS, Froguel P. From obesity genetics to the future of personalized obesity therapy. Nat Rev Endocrinol. 2013 Jul;9(7):402-13. doi: 10.1038/nrendo.2013.57. Epub 2013 Mar 26. Erratum in: Nat Rev Endocrinol. 2014 Jan;10(1):4. PMID: 23529041.
  4. Segula D. Complications of obesity in adults: a short review of the literature. Malawi Med J. 2014 Mar;26(1):20-4. PMID: 24959321; PMCID: PMC4062780.
  5. Jo J, Gavrilova O, Pack S, Jou W, Mullen S, Sumner AE, Cushman SW, Periwal V. Hypertrophy and/or Hyperplasia: Dynamics of Adipose Tissue Growth. PLoS Comput Biol. 2009 Mar;5(3):e1000324. doi: 10.1371/journal.pcbi.1000324. Epub 2009 Mar 27. PMID: 19325873; PMCID: PMC2653640.
  6. Al-Goblan AS, Al-Alfi MA, Khan MZ. Mechanism linking diabetes mellitus and obesity. Diabetes Metab Syndr Obes. 2014 Dec 4;7:587-91. doi: 10.2147/DMSO.S67400. PMID: 25506234; PMCID: PMC4259868.
  7. Cristancho AG, Lazar MA. Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol. 2011 Sep 28;12(11):722-34. doi: 10.1038/nrm3198. PMID: 21952300; PMCID: PMC7171550.
  8. Farmer SR. Transcriptional control of adipocyte formation. Cell Metab. 2006 Oct;4(4):263-73. doi: 10.1016/j.cmet.2006.07.001. PMID: 17011499; PMCID: PMC1958996.
  9. Francisco V, Pino J, Gonzalez-Gay MA, Mera A, Lago F, Gómez R, Mobasheri A, Gualillo O. Adipokines and inflammation: is it a question of weight? Br J Pharmacol. 2018 May;175(10):1569-1579. doi: 10.1111/bph.14181. Epub 2018 Apr 10. PMID: 29486050; PMCID: PMC5913397.
  10. Blüher M. Adipokines - removing road blocks to obesity and diabetes therapy. Mol Metab. 2014 Jan 21;3(3):230-40. doi: 10.1016/j.molmet.2014.01.005. PMID: 24749053; PMCID: PMC3986498.
  11. Yang J, Leng J, Li JJ, Tang JF, Li Y, Liu BL, Wen XD. Corosolic acid inhibits adipose tissue inflammation and ameliorates insulin resistance via AMPK activation in high-fat fed mice. Phytomedicine. 2016 Feb 15;23(2):181-90. doi: 10.1016/j.phymed.2015.12.018. Epub 2016 Jan 21. PMID: 26926180.
  12. Blüher M. Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes. 2009 Jun;117(6):241-50. doi: 10.1055/s-0029-1192044. Epub 2009 Apr 8. PMID: 19358089.
  13. Catalán V, Gómez-Ambrosi J, Rodríguez A, Salvador J, Frühbeck G. Adipokines in the treatment of diabetes mellitus and obesity. Expert Opin Pharmacother. 2009 Feb;10(2):239-54. doi: 10.1517/14656560802618811. PMID: 19236196.
  14. Nakamura T, Mizuno S. The discovery of Hepatocyte Growth Factor (HGF) and its significance for cell biology, life sciences and clinical medicine. Proceedings of the Japan Academy, Series B. 2010;86:588-610.
  15. Setyaningsih WAW, Sari DCR, Romi MM, Arfian N. Liver fibrosis associated with adipose tissue and liver inflammation in an obesity model. Med J Malaysia. 2021 May;76(3):304-310. PMID: 34031327.
  16. Doege H, Grimm D, Falcon A, Tsang B, Storm TA, Xu H, Ortegon AM, Kazantzis M, Kay MA, Stahl A. Silencing of hepatic fatty acid transporter protein 5 in vivo reverses diet-induced non-alcoholic fatty liver disease and improves hyperglycemia. J Biol Chem. 2008 Aug 8;283(32):22186-92. doi: 10.1074/jbc.M803510200. Epub 2008 Jun 3. PMID: 18524776; PMCID: PMC2494916.
  17. Pohl J, Ring A, Korkmaz U, Ehehalt R, Stremmel W. FAT/CD36-mediated long-chain fatty acid uptake in adipocytes requires plasma membrane rafts. Mol Biol Cell. 2005 Jan;16(1):24-31. doi: 10.1091/mbc.e04-07-0616. Epub 2004 Oct 20. PMID: 15496455; PMCID: PMC539148.
  18. Lian CY, Zhai ZZ, Li ZF, Wang L. High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms. Chem Biol Interact. 2020 Oct 1;330:109199. doi: 10.1016/j.cbi.2020.109199. Epub 2020 Aug 15. PMID: 32805210.
  19. Christensen R, Kristensen PK, Bartels EM, Bliddal H, Astrup A. Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet. 2007 Nov 17;370(9600):1706-13. doi: 10.1016/S0140-6736(07)61721-8. Erratum in: Lancet. 2008 Feb 16;371(9612):558. PMID: 18022033.
  20. Kang JG, Park CY. Anti-Obesity Drugs: A Review about Their Effects and Safety. Diabetes Metab J. 2012 Feb;36(1):13-25. doi: 10.4093/dmj.2012.36.1.13. Epub 2012 Feb 17. PMID: 22363917; PMCID: PMC3283822.
  21. Blumfield M, Abbott K, Duve E, Cassettari T, Marshall S, Fayet-Moore F. Examining the health effects and bioactive components in Agaricus bisporus mushrooms: a scoping review. J Nutr Biochem. 2020 Oct;84:108453. doi: 10.1016/j.jnutbio.2020.108453. Epub 2020 Jun 13. PMID: 32653808.
  22. Mingyi Y, Belwal T, Devkota HP, Li L, Luo Z. Trends of utilizing Mushroom Polysaccharides (MPs) as potent nutraceutical components in food and medicine: A comprehensive review. Trends in Food Science & Technology. 2019;92:94-110. doi: 10.1016/j.tifs.2019.08.009.
  23. Tietel Z, Masaphy S. True morels (Morchella)-nutritional and phytochemical composition, health benefits and flavor: A review. Crit Rev Food Sci Nutr. 2018 Jul 24;58(11):1888-1901. doi: 10.1080/10408398.2017.1285269. Epub 2017 Jul 21. PMID: 28350213.
  24. Ferreira IC, Vaz JA, Vasconcelos MH, Martins A. Compounds from wild mushrooms with antitumor potential. Anticancer Agents Med Chem. 2010 Jun;10(5):424-36. doi: 10.2174/1871520611009050424. PMID: 20545620.
  25. Hu M, Chen Y, Wang C, Cui H, Duan P, Zhai T, Yang Y, Li S. Induction of apoptosis in HepG2 cells by polysaccharide MEP-II from the fermentation broth of Morchella esculenta. Biotechnol Lett. 2013 Jan;35(1):1-10. doi: 10.1007/s10529-012-0917-4. Epub 2012 Jul 14. PMID: 22798042.
  26. Cui HL, Chen Y, Wang SS, Kai GQ, Fang YM. Isolation, partial characterisation and immunomodulatory activities of polysaccharide from Morchella esculenta. J Sci Food Agric. 2011 Sep;91(12):2180-5. doi: 10.1002/jsfa.4436. Epub 2011 May 5. PMID: 21567413.
  27. Kanwal S, Joseph TP, Owusu L, Xiaomeng R, Meiqi L, Yi X. A Polysaccharide Isolated from Dictyophora indusiata Promotes Recovery from Antibiotic-Driven Intestinal Dysbiosis and Improves Gut Epithelial Barrier Function in a Mouse Model. Nutrients. 2018 Jul 31;10(8):1003. doi: 10.3390/nu10081003. PMID: 30065236; PMCID: PMC6115818.
  28. Dubois M, Gilles KA, Hamilton JK, Rebers PT, Smith F. Colorimetric method for determination of sugars and related substances. Analytical chemistry. 1956;28:350-356.
  29. https://bit.ly/39Eproq
  30. Hao L, Sheng Z, Lu J, Tao R, Jia S. Characterization and antioxidant activities of extracellular and intracellular polysaccharides from Fomitopsis pinicola. Carbohydr Polym. 2016 May 5;141:54-9. doi: 10.1016/j.carbpol.2015.11.048. Epub 2015 Nov 19. PMID: 26876995.
  31. Liang Z, Yuan Z, Li G, Fu F, Shan Y. Hypolipidemic, Antioxidant, and Antiapoptotic Effects of Polysaccharides Extracted from Reishi Mushroom, Ganoderma lucidum (Leysser: Fr) Karst, in Mice Fed a High-Fat Diet. J Med Food. 2018 Dec;21(12):1218-1227. doi: 10.1089/jmf.2018.4182. Epub 2018 Sep 5. PMID: 30183494.
  32. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001 Dec;25(4):402-8. doi: 10.1006/meth.2001.1262. PMID: 11846609.
  33. Chang CJ, Lu CC, Lin CS, Martel J, Ko YF, Ojcius DM, Wu TR, Tsai YH, Yeh TS, Lu JJ, Lai HC, Young JD. Antrodia cinnamomea reduces obesity and modulates the gut microbiota in high-fat diet-fed mice. Int J Obes (Lond). 2018 Feb;42(2):231-243. doi: 10.1038/ijo.2017.149. Epub 2017 Jun 20. PMID: 28630461; PMCID: PMC5803574.
  34. Liu C, Peng L, Qian M, Hao J. Antihyperlipidemic effect of endo-polysaccharide of Morchella esculenta and chemical structure analysis. Oxidation Communications. 2016;39:968-976.
  35. https://bit.ly/3scnJRs
  36. van Herpen NA, Schrauwen-Hinderling VB. Lipid accumulation in non-adipose tissue and lipotoxicity. Physiol Behav. 2008 May 23;94(2):231-41. doi: 10.1016/j.physbeh.2007.11.049. Epub 2007 Dec 5. PMID: 18222498.
  37. Chang CJ, Lin CS, Lu CC, Martel J, Ko YF, Ojcius DM, Tseng SF, Wu TR, Chen YY, Young JD, Lai HC. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat Commun. 2015 Jun 23;6:7489. doi: 10.1038/ncomms8489. Erratum in: Nat Commun. 2017 Jul 11;8:16130. PMID: 26102296; PMCID: PMC4557287.
  38. Kim KA, Gu W, Lee IA, Joh EH, Kim DH. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One. 2012;7(10):e47713. doi: 10.1371/journal.pone.0047713. Epub 2012 Oct 16. PMID: 23091640; PMCID: PMC3473013.
  39. Koyama Y, Brenner DA. Liver inflammation and fibrosis. J Clin Invest. 2017 Jan 3;127(1):55-64. doi: 10.1172/JCI88881. Epub 2017 Jan 3. PMID: 28045404; PMCID: PMC5199698.
  40. Kim MH, Park SJ, Kim JH, Seong JB, Kim KM, Woo HA, Lee DS. Peroxiredoxin 5 regulates adipogenesis-attenuating oxidative stress in obese mouse models induced by a high-fat diet. Free Radic Biol Med. 2018 Aug 1;123:27-38. doi: 10.1016/j.freeradbiomed.2018.05.061. Epub 2018 May 16. PMID: 29777756.
  41. Qatanani M, Lazar MA. Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev. 2007 Jun 15;21(12):1443-55. doi: 10.1101/gad.1550907. PMID: 17575046.
  42. Khan AI, Rehman AU, Farooqui NA, Siddiqui NZ, Ayub Q, Ramzan MN, Wang L, Xin Y. Effects of Shrimp Peptide Hydrolysate on Intestinal Microbiota Restoration and Immune Modulation in Cyclophosphamide-Treated Mice. Molecules. 2022 Mar 6;27(5):1720. doi: 10.3390/molecules27051720. PMID: 35268821; PMCID: PMC8911659.
  43. Delarue J, Magnan C. Free fatty acids and insulin resistance. Curr Opin Clin Nutr Metab Care. 2007 Mar;10(2):142-8. doi: 10.1097/MCO.0b013e328042ba90. PMID: 17285001.
  44. Lu Y , Zhao A , Wu Y , Zhao Y , Yang X . Soybean soluble polysaccharides enhance bioavailability of genistein and its prevention against obesity and metabolic syndrome of mice with chronic high fat consumption. Food Funct. 2019 Jul 17;10(7):4153-4165. doi: 10.1039/c8fo02379d. PMID: 31241065.
  45. Han MS, Jung DY, Morel C, Lakhani SA, Kim JK, Flavell RA, Davis RJ. JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science. 2013 Jan 11;339(6116):218-22. doi: 10.1126/science.1227568. Epub 2012 Dec 6. PMID: 23223452; PMCID: PMC3835653.
  46. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med. 2005 Feb;11(2):183-90. doi: 10.1038/nm1166. Epub 2005 Jan 30. PMID: 15685173; PMCID: PMC1440292.
  47. Haeusler RA, McGraw TE, Accili D. Biochemical and cellular properties of insulin receptor signalling. Nat Rev Mol Cell Biol. 2018 Jan;19(1):31-44. doi: 10.1038/nrm.2017.89. Epub 2017 Oct 4. PMID: 28974775; PMCID: PMC5894887.
  48. Ghanim H, Abuaysheh S, Sia CL, Korzeniewski K, Chaudhuri A, Fernandez-Real JM, Dandona P. Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: implications for insulin resistance. Diabetes Care. 2009 Dec;32(12):2281-7. doi: 10.2337/dc09-0979. Epub 2009 Sep 15. PMID: 19755625; PMCID: PMC2782991.
  49. Schreiber S, Nikolaus S, Hampe J. Activation of nuclear factor kappa B inflammatory bowel disease. Gut. 1998 Apr;42(4):477-84. doi: 10.1136/gut.42.4.477. PMID: 9616307; PMCID: PMC1727068.
  50. Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol. 2010 Jan 15;314(1):1-16. doi: 10.1016/j.mce.2009.07.031. Epub 2009 Aug 12. PMID: 19682539.
  51. Cancello R, Tordjman J, Poitou C, Guilhem G, Bouillot JL, Hugol D, Coussieu C, Basdevant A, Bar Hen A, Bedossa P, Guerre-Millo M, Clément K. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes. 2006 Jun;55(6):1554-61. doi: 10.2337/db06-0133. PMID: 16731817.
Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable
Submit Manuscript Membership